Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8726857 | Gastroenterology | 2018 | 32 Pages |
Abstract
In a post hoc analysis of data from a phase III study of the effects of teduglutide on patients with SBS, we associated reduced parenteral support volume with baseline parenteral support volume, bowel anatomy, and SBS features. These findings may inform initial parenteral support volume adjustments and management of these severely disabled patients. ClinicalTrials.gov no: NCT00798967; ClinicalTrialsRegister.eu no: 2008-006193-15.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Palle B. Jeppesen, Simon M. Gabe, Douglas L. Seidner, Hak-Myung Lee, Clément Olivier,